337 related articles for article (PubMed ID: 18304744)
1. Delivery of interferon-beta to the monkey nervous system following intranasal administration.
Thorne RG; Hanson LR; Ross TM; Tung D; Frey WH
Neuroscience; 2008 Mar; 152(3):785-97. PubMed ID: 18304744
[TBL] [Abstract][Full Text] [Related]
2. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
3. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.
Ross TM; Martinez PM; Renner JC; Thorne RG; Hanson LR; Frey WH
J Neuroimmunol; 2004 Jun; 151(1-2):66-77. PubMed ID: 15145605
[TBL] [Abstract][Full Text] [Related]
5. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
Dhuria SV; Hanson LR; Frey WH
J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration delivers peptoids to the rat central nervous system.
Ross TM; Zuckermann RN; Reinhard C; Frey WH
Neurosci Lett; 2008 Jul; 439(1):30-3. PubMed ID: 18501511
[TBL] [Abstract][Full Text] [Related]
7. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.
Li F; Feng J; Cheng Q; Zhu W; Jin Y
Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426
[TBL] [Abstract][Full Text] [Related]
8. Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents.
Westin U; Piras E; Jansson B; Bergström U; Dahlin M; Brittebo E; Björk E
Eur J Pharm Sci; 2005 Apr; 24(5):565-73. PubMed ID: 15784346
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway.
Renner DB; Frey WH; Hanson LR
Neurosci Lett; 2012 Apr; 513(2):193-7. PubMed ID: 22387067
[TBL] [Abstract][Full Text] [Related]
10. Transfer of some carboxylic acids in the olfactory system following intranasal administration.
Eriksson C; Bergman U; Franzén A; Sjöblom M; Brittebo EB
J Drug Target; 1999; 7(2):131-42. PubMed ID: 10617298
[TBL] [Abstract][Full Text] [Related]
11. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
Yu H; Kim K
Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of insulin via the olfactory nerve pathway.
Renner DB; Svitak AL; Gallus NJ; Ericson ME; Frey WH; Hanson LR
J Pharm Pharmacol; 2012 Dec; 64(12):1709-14. PubMed ID: 23146033
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis.
Kraus J; Bauer R; Chatzimanolis N; Engelhardt B; Tofighi J; Bregenzer T; Kuehne BS; Stolz E; Blaes F; Morgen K; Traupe H; Kaps M; Oschmann P
J Neurol; 2004 Apr; 251(4):464-72. PubMed ID: 15083294
[TBL] [Abstract][Full Text] [Related]
14. Brain distribution of ribavirin after intranasal administration.
Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.
Carmona O; Casado V; Moral E; Alonso-Magdalena L; Martínez-Yélamos A; Martínez-Yélamos S; Martín-Ozaeta G; Arbizu T
Eur Neurol; 2008; 60(6):279-84. PubMed ID: 18824855
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of cells to the brain.
Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Buadze M; Geisler J; Klopfer T; Burkhardt U; Proksch B; Verleysdonk S; Ayturan M; Buniatian GH; Gleiter CH; Frey WH
Eur J Cell Biol; 2009 Jun; 88(6):315-24. PubMed ID: 19324456
[TBL] [Abstract][Full Text] [Related]
17. Methimazole toxicity in rodents: covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb.
Bergman U; Brittebo EB
Toxicol Appl Pharmacol; 1999 Mar; 155(2):190-200. PubMed ID: 10053173
[TBL] [Abstract][Full Text] [Related]
18. Olfactory primary neurons as a route of entry for toxic agents into the CNS.
Hastings L; Evans JE
Neurotoxicology; 1991; 12(4):707-14. PubMed ID: 1795897
[TBL] [Abstract][Full Text] [Related]
19. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
20. Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins.
Nonaka N; Farr SA; Kageyama H; Shioda S; Banks WA
J Pharmacol Exp Ther; 2008 May; 325(2):513-9. PubMed ID: 18270319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
